Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2017

Summary of the components of collaboration revenue

Below is a summary of the components of the Company’s collaboration revenue for the three months ended March 31, 2017 and 2016:



	Three months ended March 31,
	2017		2016

License revenue	$	—	$	—
Research and development activity revenue	1,658		1,275
API transfer revenue	—		14,443
Joint operating committee revenue	4		3
Total collaboration revenue	$	1,662	$	15,721

Schedule of share-based compensation expense

Share-based compensation expense includes expenses related to stock options and RSUs granted to employees, non-employee directors and consultants, as well as the option granted to employees to purchase shares under the ESPP, all of which have been reported in the Company’s Statements of Operations as follows:



	Three months ended March 31,
	2017		2016

Research and development	$	4,150	$	4,685
General and administrative	1,914		3,647
Total	$	6,064	$	8,332